HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
MTVA
MetaVia Inc.
There isn't enough reported data to score MTVA yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
MTVA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
MTVA's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
MTVA PE Valuation
MTVA has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
MTVA Forward outlook
There aren't enough analyst estimates for MTVA to show an outlook.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
MTVA has the stronger earnings trend. Trailing diluted EPS is down 257% for HIMS versus MTVA down 132%.
MTVA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$53.02 | +$111.54 |
| Q2 2024 | -$54.89 | +$409.75 |
| Q1 2024 | -$36.30 | +$743.38 |
| Q4 2023 | -$27.06 | +$1,037.74 |
| Q3 2023 | -$164.56 | +$1,199.44 |
| Q2 2023 | -$464.64 | +$1,013.76 |
| Q1 2023 | -$779.68 | +$857.12 |
| Q4 2022 | -$1,064.80 | +$677.60 |
MTVA lost $53.02 per share over the past year, a smaller loss than the year before.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS's revenue has grown year over year every quarter since late 2021: $890M last quarter, up 49% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
MTVA Quarterly Revenue
MTVA and HIMS do not have enough comparable growth data to identify a winner.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
MTVA has the stronger cash trend. Its trailing FCF is down 18% versus its history, compared with HIMS at down 84%.
MTVA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$4.9M | +$568K |
| Q3 2025 | -$3M | +$2.6M |
| Q4 2024 | -$5.4M | -$2M |
| Q3 2024 | -$5.6M | -$2.7M |
| Q2 2024 | -$7.3M | -$5.2M |
| Q1 2024 | -$6.4M | -$3.9M |
| Q1 2023 | -$2.6M | +$2.3M |
| Q4 2021 | -$2.9M | -$549K |
MTVA has burned cash in almost every quarter: −$18M over the past year, against −$23M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over MTVA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
MTVA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +22% | +1.1M shares |
| 1 year | +536% | +5M shares |
| 3 years | +58637% | +5.9M shares |
| 5 years | +95237% | +5.9M shares |
MTVA has 6M diluted shares, up 536% from a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
MTVA Net Leverage
MTVA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
MTVA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.9 | Neutral |
| Stochastic | 25.9 | Neutral |
MTVA's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
MTVA PE vs Healthcare Sector
MTVA has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
MTVA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.39 | 6.5% below |
| 20 week MA | $1.51 | 14% below |
| 50 week MA | $2.54 | 49% below |
| 100 week MA | $7.22 | 82% below |
| 200 week MA | $26.2 | 95% below |
MTVA is in a downtrend: it's below all five of its weekly moving averages, and 95% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over MTVA on returns for 2026, with the stronger performance.
MTVA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19,866.0 | $16,077.6 | -19% |
| 2021 | $16,077.6 | $4,012.8 | -75% |
| 2022 | $4,012.8 | $71.6 | -98% |
| 2023 | $71.6 | $40.7 | -43% |
| 2024 | $40.7 | $19.4 | -52% |
| 2025 | $19.4 | $9.19 | -53% |
| 2026 YTD | $9.19 | $1.30 | -86% |
MTVA has finished every year since 2020 lower, and it's down 86% so far in 2026.